527 related articles for article (PubMed ID: 12062589)
1. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
Caillé S; Espejo EF; Koob GF; Stinus L
Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
[TBL] [Abstract][Full Text] [Related]
2. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
Pinelli A; Trivulzio S
J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
Caillé S; Stinus L; Espejo EF; De Deurwaerdère P; Spampinato U; Koob GF
Neuropsychopharmacology; 2003 Feb; 28(2):276-83. PubMed ID: 12589380
[TBL] [Abstract][Full Text] [Related]
5. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
Streel E; Dan B; Campanella S; Meyvaert A; Hanak C; Pelc I; Verbanck P
Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582
[TBL] [Abstract][Full Text] [Related]
6. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
[TBL] [Abstract][Full Text] [Related]
7. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
[TBL] [Abstract][Full Text] [Related]
8. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
[TBL] [Abstract][Full Text] [Related]
9. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
12. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.
Harris AC; Gewirtz JC
Psychopharmacology (Berl); 2004 Jan; 171(2):140-7. PubMed ID: 13680079
[TBL] [Abstract][Full Text] [Related]
13. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
14. Blocking naloxone-precipitated withdrawal in rats and hamsters.
Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
[TBL] [Abstract][Full Text] [Related]
16. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
Kosten TA
Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
[TBL] [Abstract][Full Text] [Related]
17. Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus.
Lunden JW; Kirby LG
Neuroscience; 2013 Dec; 254():160-72. PubMed ID: 24055683
[TBL] [Abstract][Full Text] [Related]
18. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.
Silverstone PH; Done C; Sharp T
Psychopharmacology (Berl); 1992; 109(1-2):235-8. PubMed ID: 1365663
[TBL] [Abstract][Full Text] [Related]
19. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
Pinelli A; Trivulzio S; Spezia R
Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
